Peter M. Tessier

6.9k total citations
106 papers, 5.3k citations indexed

About

Peter M. Tessier is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Physiology. According to data from OpenAlex, Peter M. Tessier has authored 106 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Molecular Biology, 73 papers in Radiology, Nuclear Medicine and Imaging and 17 papers in Physiology. Recurrent topics in Peter M. Tessier's work include Monoclonal and Polyclonal Antibodies Research (72 papers), Protein purification and stability (52 papers) and Glycosylation and Glycoproteins Research (29 papers). Peter M. Tessier is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (72 papers), Protein purification and stability (52 papers) and Glycosylation and Glycoproteins Research (29 papers). Peter M. Tessier collaborates with scholars based in United States, Germany and Denmark. Peter M. Tessier's co-authors include Abraham M. Lenhoff, Ali Reza A. Ladiwala, Orlin D. Velev, Joseph M. Perchiacca, E. W. Kaler, Kathryn E. Tiller, Jonathan S. Dordick, Stanley I. Sandler, Susan Lindquist and John F. Rabolt and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Peter M. Tessier

105 papers receiving 5.1k citations

Peers

Countries citing papers authored by Peter M. Tessier

Since Specialization

Citations

This map shows the geographic impact of Peter M. Tessier's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter M. Tessier with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter M. Tessier more than expected).

Fields of papers citing papers by Peter M. Tessier

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter M. Tessier. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter M. Tessier. The network helps show where Peter M. Tessier may publish in the future.

Co-authorship network of co-authors of Peter M. Tessier

This figure shows the co-authorship network connecting the top 25 collaborators of Peter M. Tessier. A scholar is included among the top collaborators of Peter M. Tessier based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter M. Tessier. Peter M. Tessier is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Facile generation of drug-like conformational antibodies specific for amyloid fibrils 2025 ·Nature Chemical Biology ·Alec A. Desai, Jennifer M. Zupancic, Hanna Trzeciakiewicz, Julia E. Gerson, (unknown), Mary E. Skinner, Lisa M. Sharkey, (unknown), Sean P. Ferris, Nemil Bhatt, Emily K. Makowski, Matthew D. Smith, Hongwei Chen, (unknown), (unknown), (unknown), Ravi S. Kane, Nicholas M. Kanaan, Henry L. Paulson, Peter M. Tessier	1
2	In Vivo Auto-tuning of Antibody–Drug Conjugate Delivery to Maximize Efficacy Using High-Avidity, Low-Affinity Antibodies 2025 ·Molecular Cancer Therapeutics ·(unknown), (unknown), (unknown), (unknown), Alec A. Desai, (unknown), (unknown), Jennifer J. Linderman, Peter M. Tessier, Greg M. Thurber	0
3	Maximizing activity and selectivity of antibody-mediated effector functions using antibody mixtures 2025 ·mAbs ·Tiexin Wang, Alec A. Desai, Greg M. Thurber, Peter M. Tessier	1
4	Generation of nanobodies with conformational specificity for tau oligomers that recognize tau aggregates from human Alzheimer's disease samples 2024 ·Biomaterials Science ·(unknown), (unknown), (unknown), Nemil Bhatt, (unknown), (unknown), Peter M. Tessier, Levi B. Wood, Rakez Kayed, Ravi S. Kane	3
5	Human antibody polyreactivity is governed primarily by the heavy-chain complementarity-determining regions 2024 ·Cell Reports ·(unknown), Yulei Zhang, (unknown), (unknown), Matthew D. Smith, (unknown), Alec A. Desai, Emily K. Makowski, Giuseppe Licari, Yunxuan Xie, Michael S. Marlow, Sandeep Kumar, Peter M. Tessier	4
6	Optimization of therapeutic antibodies for reduced self-association and non-specific binding via interpretable machine learning 2023 ·Nature Biomedical Engineering ·Emily K. Makowski, (unknown), Jennifer M. Zupancic, Jie Huang, Lina Wu, John S. Schardt, Anne S. De Groot, (unknown), William Martin, Peter M. Tessier	21
7	Computational optimization of antibody humanness and stability by systematic energy-based ranking 2023 ·Nature Biomedical Engineering ·(unknown), (unknown), (unknown), (unknown), Ashish Noronha, Moshit Lindzen, Emily K. Makowski, (unknown), (unknown), (unknown), Peter M. Tessier, Jakub Abramson, Yosef Yarden, Deborah Fass, Sarel J. Fleishman	19
8	Bispecific antibody shuttles targeting CD98hc mediate efficient and long-lived brain delivery of IgGs 2023 ·Cell chemical biology ·(unknown), (unknown), Michael J. Lucas, Jennifer M. Zupancic, (unknown), Boya Zhang, Colin F. Greineder, Peter M. Tessier	31
9	Rapid and Quantitative In Vitro Evaluation of SARS-CoV-2 Neutralizing Antibodies and Nanobodies 2022 ·Analytical Chemistry ·(unknown), Xiaotian Tan, Jennifer M. Zupancic, John S. Schardt, Alec A. Desai, Matthew D. Smith, Jie Zhang, Liangzhi Xie, (unknown), Peter M. Tessier, Xudong Fan	3
10	Antibodies with Weakly Basic Isoelectric Points Minimize Trade-offs between Formulation and Physiological Colloidal Properties 2022 ·Molecular Pharmaceutics ·Priyanka Gupta, Emily K. Makowski, Sandeep Kumar, Yulei Zhang, Justin M. Scheer, Peter M. Tessier	26
11	A hybridoma-derived monoclonal antibody with high homology to the aberrant myeloma light chain 2021 ·PLoS ONE ·(unknown), (unknown), Alec A. Desai, (unknown), (unknown), Peter M. Tessier, Colin F. Greineder	5
12	Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS‐CoV‐2 Variants 2021 ·Advanced Therapeutics ·Jennifer M. Zupancic, John S. Schardt, Alec A. Desai, Emily K. Makowski, Matthew D. Smith, (unknown), Mayara Garcia de Mattos Barbosa, Marília Cascalho, Thomas M. Lanigan, Peter M. Tessier	30
13	Discovery-stage identification of drug-like antibodies using emerging experimental and computational methods 2021 ·mAbs ·Emily K. Makowski, Lina Wu, Priyanka Gupta, Peter M. Tessier	41
14	An engineered human Fc domain that behaves like a pH-toggle switch for ultra-long circulation persistence 2019 ·Nature Communications ·Chang‐Han Lee, Tae Hyun Kang, Ophélie Godon, Makiko Watanabe, George Delidakis, Caitlin M. Gillis, Delphine Sterlin, David Hardy, Michel Cogné, Lynn E. Macdonald, Andrew Murphy, Naxin Tu, Jiwon Lee, Jonathan R. McDaniel, Emily K. Makowski, Peter M. Tessier, Aaron S. Meyer, Pierre Bruhns, George Georgiou	54
15	Sensitive detection of glucagon aggregation using amyloid fibril‐specific antibodies 2019 ·Biotechnology and Bioengineering ·(unknown), (unknown), Alec A. Desai, Jesper E. Mogensen, (unknown), (unknown), Arne Staby, Peter M. Tessier	8
16	Deamidation Can Compromise Antibody Colloidal Stability and Enhance Aggregation in a pH-Dependent Manner 2019 ·Molecular Pharmaceutics ·(unknown), Gregory V. Barnett, Thomas R. Slaney, Charles G. Starr, Tapan K. Das, Peter M. Tessier	27
17	Directed evolution methods for overcoming trade‐offs between protein activity and stability 2019 ·AIChE Journal ·(unknown), Matthew D. Smith, Peter M. Tessier	39
18	Selecting and engineering monoclonal antibodies with drug-like specificity 2019 ·Current Opinion in Biotechnology ·Charles G. Starr, Peter M. Tessier	62
19	Rational design of potent domain antibody inhibitors of amyloid fibril assembly 2012 ·Proceedings of the National Academy of Sciences ·Ali Reza A. Ladiwala, (unknown), Joseph M. Perchiacca, Ping Cao, Daniel P. Raleigh, Andisheh Abedini, Ann Marie Schmidt, Jobin Varkey, Ralf Langen, Peter M. Tessier	88
20	Structure-based design of conformation- and sequence-specific antibodies against amyloid β 2011 ·Proceedings of the National Academy of Sciences ·Joseph M. Perchiacca, Ali Reza A. Ladiwala, (unknown), Peter M. Tessier	115

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact